Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice

BACKGROUND/OBJECTIVE: This study compares the effectiveness and safety of intranasal versus subcutaneous administration of dantrolene in 5XFAD Alzheimer’s disease (AD) mice. METHODS: 5XFAD and wild type (WT) B6SJLF1/J mice were treated with intranasal or subcutaneous dantrolene (5 mg/kg, 3×/wk), or...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yun, Zhang, Lei, Gao, Xue, Zhang, Jing, Ben Abou, Matan, Liang, Ge, Meng, Qingcheng, Hepner, Adrian, Eckenhoff, Maryellen F., Wei, Huafeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505009/
https://www.ncbi.nlm.nih.gov/pubmed/32623395
http://dx.doi.org/10.3233/JAD-200227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505009/
https://www.ncbi.nlm.nih.gov/pubmed/32623395
http://dx.doi.org/10.3233/JAD-200227

Ejemplares similares